Exercise for Chronic Pediatric Conditions
(Project REACH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how exercise affects children with chronic conditions such as cystic fibrosis (CF), sickle cell disease (SCD), and those who have had COVID-19. Exercise tests measure how these children's bodies respond to physical activity. The goal is to develop better methods to test and improve exercise plans for them. Children with CF or SCD, or those who have experienced COVID-19 and can exercise without issues, might be suitable candidates for this study. As an unphased trial, this study offers a unique opportunity for children to contribute to research that could enhance exercise plans for others with similar conditions.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that chronic medication use is an exclusion criterion for healthy controls and those with a history of SARS-CoV-2 infection. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that this exercise protocol is safe for children with chronic conditions?
Research shows that exercise is generally safe for children with conditions like cystic fibrosis (CF), a history of COVID-19, and sickle cell disease (SCD). For children with CF, studies indicate that exercise rarely causes side effects, making it a safe way to boost fitness and health.
In children who have had COVID-19, most do not experience heart or lung problems from mild infections, suggesting that exercise is safe for them too.
For those with sickle cell disease, recent research suggests that controlled exercise does not cause problems and is well tolerated, indicating it is generally safe and can be helpful.
Overall, exercise appears to be a safe and beneficial activity for kids with these chronic conditions, improving their health and quality of life.12345Why are researchers excited about this trial?
Researchers are excited about the exercise protocol being tested because it offers a non-invasive way to boost health in children with chronic conditions like cystic fibrosis, past SARS-CoV-2 infection, and sickle cell disease. Unlike conventional treatments that often rely on medication, this approach focuses on improving cardiorespiratory fitness through structured exercise, potentially offering fewer side effects. Additionally, the study aims to gather important data on how exercise impacts blood markers, providing insights that could lead to personalized exercise recommendations for these conditions.
What evidence suggests that this trial's exercise treatments could be effective for chronic pediatric conditions?
This trial will evaluate the effects of exercise on children with chronic conditions, including cystic fibrosis (CF), sickle cell disease (SCD), and those with a history of COVID-19 infection. Research has shown that exercise can be very helpful for these groups. Participants in the CF arm may experience improved lung function, fitness, and overall quality of life through regular exercise, which also strengthens muscles and heart health. In the arm for children with a history of COVID-19, exercise can improve heart and lung fitness and general health, addressing the reduced activity levels seen during the pandemic. For those in the SCD arm, light to moderate exercise is generally safe and can aid in muscle growth. Although some debate exists, exercise is usually seen as a beneficial addition to treatment plans for these conditions.16789
Are You a Good Fit for This Trial?
Children aged approximately 10-17 with cystic fibrosis, sickle cell disease, or past SARS-CoV-2 infection are eligible for this exercise study if they're in good health and have no other conditions that limit physical activity. They must be at a stage of puberty as defined by Tanner stages 1-5 and have physician approval to perform exercise tests.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Cardiopulmonary Exercise Test (CPET) to measure cardiorespiratory responses, with blood sampling at multiple time points
Follow-up
Participants are monitored for safety and effectiveness after treatment, including gene expression and body composition assessments
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Children's Hospital of Orange County
Collaborator
Children's Hospital Los Angeles
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Children's Hospital of Orange County (CHOC)
Collaborator
Children's Hospital of Los Angeles (CHLA)
Collaborator
Lurie Children's Hospital in Chicago
Collaborator